SQUAWK/NEWS
Menu
Live News EQUITY FLASH H impact

IOVA falls 8.4% on REPL melanoma treatment

IOVA shares drop on competing treatment news

IOVAREPL

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.